The new findings are particularly relevant for people considering the drugs who have other known optic nerve problems like glaucoma or if there is preexisting significant visual loss from other causes, Rizzo said
Retatrutide won't be available until at least early 2026 as it's still in phase-3 clinical trials
Kidney injury was assessed based on the presence and severity of lymphatic infiltration, tubular degeneration, glomerular fragmentation, and vacuolation
Contraindications Disruption of the Hypothalamic-pituitary Axis Tesamorelin is contraindicated in patients with disruption of the hypothalamic-pituitary axis due to hypophysectomy, hypopituitarism, pituitary tumor/surgery, head irradiation or head trauma
Pasireotide frequently causes severe hyperglycemia, probably by activating somatostatin receptor 5 expressed in the pancreases and intestines 17,18
Glucagon Reduction : By decreasing glucagon levels, it prevents the liver from producing excessive glucose